STABILITY INDICATING HPLC METHOD FOR THE DETERMINATION OF ESLICARBAZEPINE ACETATE AND ITS IMPURITIES IN BULK DRUGS AND PHARMACEUTICAL DOSAGE FORMS

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Liquid Chromatography & Related Technologies

• Publication date

  2012-03-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/10826076.2011.619043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Eslicarbazepine acetate (BIA 2-093)

  2011cited by this paper
• Development of liquid chromatographic enantiomer separation methods and validation for the estimation of (R)-enantiomer in eslicarbazepine acetate.

  2011cited by this paper
• Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma

  2010cited by this paper
• Key factors in the discovery and development of new antiepileptic drugs

  2010cited by this paper
• Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection.

  2007cited by this paper
• Single‐Dose and Steady‐State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2–093) in Healthy Elderly and Young Subjects

  2005cited by this paper
• Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).

  2004cited by this paper
• The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.

  2002cited by this paper
• Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine.

  2001cited by this paper

• Zirconia nanoparticles/carbon quantum dots modified carbon paste electrode as electrochemical sensor for determination of antiepileptic drug eslicarbazepine acetate in bulk and pharmaceutical dosage form

  2024cites this paper
• An overview of liquid chromatographic methods for analyzing new generation anti-epileptic drugs

  2022cites this paper
• A chiral electrokinetic chromatography method for the separation and quantitation of licarbazepine and licarbazepine acetate in pharmaceutical formulations and urine samples

  2022cites this paper
• Stability Indicating Methods for Determination of Third Generation Antiepileptic Drugs and Their Related Substances

  2021cites this paper
• The synergistic effect of zeolites and polyethylene glycol for the determination of the anti-epileptic drug eslicarbazepine acetate and its metabolite

  2020cites this paper
• Development of a stress induced validated UPLC-PDA method for the analysis of Eslicarbazepine acetate

  2017influential citation
• The use of separation techniques in the analysis of some antiepileptic drugs: A critical review

  2016cites this paper
• Understanding unconventional routes to impurities from drugs in hydrolytic conditions

  2016cites this paper
• FT-IR Spectroscopic Assay Method for Eslicarbazepine Acetate in Bulk and Tablet Formulations

  2015cites this paper
• Development and validation of an RP-HPLC method for related substance and quantitative estimation of eslicarbazepine acetate in bulk drug and pharmaceutical dosage form

  2015cites this paper
• Identification, synthesis and characterization of an unknown process related impurity in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI–IT/MS, 1H, 13C and 1H–1H COSY NMR

  2013cites this paper
• Development and Validation of an RP-HPLC Method for Quantitative Estimation of Eslicarbazepine Acetate in Bulk Drug and Tablets

  2013cites this paper